Tae K, El-Naggar A K, Yoo E, Feng L, Lee J J, Hong W K, Hittelman W N, Shin D M
Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.
Clin Cancer Res. 2000 Jul;6(7):2821-8.
Angiogenesis is a fundamental process in tumor growth and metastasis, and its significance and that of vascular endothelial growth factor (VEGF) expression as prognostic indicators have been documented for various types of human tumors. However, the mechanisms responsible for angiogenesis in head and neck squamous cell carcinoma are not well defined. To examine the relationship between angiogenesis and the phenotypic progressions of head and neck tumorigenesis, we used immunohistochemistry to analyze VEGF expression and microvessel density in 70 paraffin-embedded specimens that contained adjacent normal epithelium, premalignant lesions, or both from 57 patients with head and neck squamous cell carcinoma. Ten samples of normal oral mucosa were obtained from people who did not smoke or drink alcohol and included in the analysis as normal controls. Microvessel density was evaluated by averaging 10 microscopic fields (x400) in a defined area of each specimen. The degree of VEGF expression was assessed on a cell-by-cell basis in 10 microscopic fields (x200) in a defined area on a scale ranging from 0 (no expression) to 3+ (highest level of expression). In addition, the weighted mean index of VEGF expression was calculated. The mean +/- SD weighted mean index of VEGF expression in normal control epithelium (1.10 +/- 0.38, n = 10) was higher than it was in adjacent normal epithelium (0.82 +/- 0.27, n = 13; P = 0.04). VEGF expression decreased as samples ranged from normal adjacent epithelium to hyperplasia (0.78 +/- 0.28, n = 21), mild dysplasia (0.70 +/- 0.29, n = 28), moderate dysplasia (0.67 +/- 0.29, n = 11), severe dysplasia (0.51 +/- 0.39, n = 6), and squamous cell carcinoma (0.20 +/- 0.27, n = 70; overall P = 0.0001). VEGF expression was two times lower in cases with nodal disease (0.17 +/- 0.26, n = 29) than it was in nonnodal disease (0.32 +/- 0.29, n = 16; P = 0.02). Microvessel density showed no significant difference from adjacent normal epithelium premalignant lesions to cancer. In tumor, no correlation was seen between VEGF expression or microvessel density and differentiation, primary tumor site, T stage, or smoking status. These findings indicate that VEGF expression is down-regulated during head and neck tumorigenesis. However, further studies are required to better understand the mechanism of VEGF down-regulation in head and neck tumorigenesis.
血管生成是肿瘤生长和转移的一个基本过程,血管生成及其重要性以及血管内皮生长因子(VEGF)表达作为预后指标在各类人类肿瘤中均有记载。然而,头颈部鳞状细胞癌中血管生成的机制尚未完全明确。为了研究血管生成与头颈部肿瘤发生表型进展之间的关系,我们采用免疫组织化学方法分析了57名头颈部鳞状细胞癌患者的70个石蜡包埋标本中VEGF的表达和微血管密度,这些标本包含相邻正常上皮、癌前病变或两者皆有。从不吸烟和不饮酒的人群中获取10份正常口腔黏膜样本作为正常对照纳入分析。通过对每个标本特定区域内10个显微镜视野(×400)取平均值来评估微血管密度。在每个标本特定区域的10个显微镜视野(×200)中,逐细胞评估VEGF的表达程度,范围从0(无表达)到3 +(最高表达水平)。此外,还计算了VEGF表达的加权平均指数。正常对照上皮中VEGF表达的平均±标准差加权平均指数为(1.10±0.38,n = 10),高于相邻正常上皮(0.82±0.27,n = 13;P = 0.04)。随着样本从正常相邻上皮到增生(0.78±0.28,n = 21)、轻度发育异常(0.70±0.29,n = 28)、中度发育异常(0.67±0.29,n = 11)、重度发育异常(0.51±0.39,n = 6)以及鳞状细胞癌(0.20±0.27,n = 70;总体P = 0.0001),VEGF表达逐渐降低。有淋巴结转移病例的VEGF表达(0.17±0.26,n = 29)比无淋巴结转移病例(0.32±0.29,n = 16;P = 0.02)低两倍。从相邻正常上皮、癌前病变到癌,微血管密度无显著差异。在肿瘤中,未发现VEGF表达或微血管密度与分化、原发肿瘤部位、T分期或吸烟状态之间存在相关性。这些发现表明,在头颈部肿瘤发生过程中VEGF表达下调。然而,需要进一步研究以更好地理解头颈部肿瘤发生过程中VEGF下调的机制。